FLGT Q4 2017 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q4 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$4M-26.9% YoY

Gross Profit

$2M40.6% margin

Operating Income

-$2M-48.4% margin

Net Income

-$2M-37.9% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

-4.9%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$581,000

Balance Sheet

Total Assets

$57M

Total Liabilities

$3M

Stockholders' Equity

$54M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$6M	-26.9%
Gross Profit	$2M	$4M	-56.5%
Operating Income	-$2M	$1M	-264.4%
Net Income	-$2M	$813,000	-299.8%

Geographic Segments

UNITED STATES

$2M57%

CANADA

$923,00022%

Other Countries

$895,00021%

CHINA

$6,0000%